+91-8026982400
[email protected]

Our Blog

June 05, 2018

Kemwell Biopharma Selected To Manufacture The Monoclonal Antibody Drug Substance For A US Phase 3 Clinical Trial

BANGALORE, India, June 5, 2018 /PRNewswire/ -- Kemwell Biopharma, a biologics contract development and manufacturing service provider, announced…

Read More

Recent Posts

25 May 2022
Kemwell Experience In Successful Scale-Ups For Mammalian Cell-Culture…
22 June 2020
High throughput screening for optimization of purification process…
22 June 2020
Kemwell’s Approach To Scale-Up Of Fed-Batch Cell Culture…
10 September 2019
Effective Client-CMO Collaboration Through Strong Data Security

New at Kemwell

A collection of stories about our people, our capabilities, our research,
and the ever-changing face of our firm.

Uncategorized
25 May 2022
Kemwell Experience In Successful Scale-Ups For Mammalian Cell-Culture Processes To…

Madhava Ram Paranandi, Sr. Director, MSATM Scale-up of a cell culture…

Read More
Case Study
22 June 2020
High throughput screening for optimization of purification process – CDMO…

With the recent advances in biotechnology, there has been a considerable…

Read More
Uncategorized
22 June 2020
Kemwell’s Approach To Scale-Up Of Fed-Batch Cell Culture Processes

Kemwell, a leading contract manufacturing organization, has been working on projects…

Read More

Get in Touch



    [email protected]
    +91-8026982400
    Company
    Services
    Download Brochure
    Company
    Services
    Download Brochure

    ©2024 KEMWELL, All Rights Reserved |
    Designed by Lucid Design

    Kemwell Pharma